🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07733271
Recruiting Not applicable

Robot-Assisted Closed Reduction and Internal Fixation for Extra-Articular Distal Tibial Fractures

NCT07733271 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Jishuitan Hospital
Phase
Not applicable
Started
2026-07-01
Last updated
2026-07-29

Condition(s) studied

Distal Tibial FractureTibial Fractures

Investigational drug(s) / intervention(s)

Robot-assisted closed reductionTraditional surgeon-led reduction

Robot-assisted closed reduction: The patient undergoes automated or human-robot collaborative closed fracture reduction powered by an intelligent robotic system. The system integrates deep-learning-based bone segmentation, automatic reduction planning, and a self-adaptive 2D-3D image registration framework to achieve sub-millimeter positioning feedback and force-position collaborative security gates. Following successful reduction, the fracture is fixed with a distal tibial locking plate via the minimally invasive percutaneous plate osteosynthesis (MIPO) technique.

Traditional surgeon-led reduction: The patient undergoes conventional closed or open fracture reduction performed entirely by the surgical team based on traditional clinical experience under ordinary C-arm fluoroscopic guidance. Internal fixation is achieved using standard distal tibial locking plates or intramedullary nails according to the surgeon's choice and standard of care.

Study summary

This study aims to evaluate the clinical efficacy and safety of an intelligent fracture reduction robot system in treating extra-articular distal tibial fractures. Traditional manual bone setting depends heavily on a surgeon's experience, which can sometimes lead to inconsistent alignment and increased radiation exposure. This clinical trial compares robot-assisted closed reduction against the traditional surgeon-led method. The primary goal is to determine if the robotic system improves the rate of accurate fracture alignment (excellent and good reduction rate) and helps patients recover better.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Unilateral, acute, closed distal tibial fractures (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 43-A) * Time from injury to surgery \< 21 days * Able to walk independently before injury (assistive devices allowed) Exclusion Criteria: * Open fractures or multiple severe traumas requiring priority treatment * Asymmetrical lower extremities, or prior malunion of the ipsilateral tibia, or pre-existing deformities significantly affecting rotation/length evaluation * Ipsilateral fractures combined with other sites * Pathological fractures (tumor/metabolic) * Prior complex implants in place or previous surgeries significantly affecting evaluation * Active infection or severe systemic medical contraindications (unable to tolerate anesthesia/surgery) * Cognitive impairment, poor compliance, pregnancy, or lactation * Poor local skin conditions (e.g., obvious blisters, severe soft tissue injury) * Deemed unsuitable by the investigator (e.g., unable to follow up as planned) or refused randomization/enrollment

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Aerospace Center Hospital Beijing Beijing Municipality Recruiting
Beijing Jishuitan Hospital Beijing Beijing Municipality Recruiting

More Beijing Jishuitan Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07733271 on ClinicalTrials.gov ↗ ← All trials in China